Thursday, November 26, 05:20 pm IST
Hot Searches:  mahindra satyamITCtata steel
| Feedback
Moneycontrol » News Center » Business » Business News
Novartis drops Exelon patent suit against Sun Pharma
Published on Thu, Dec 06, 2007 at 08:36   |  Updated at Thu, Dec 06, 2007 at 09:03  |  Source : Business Line

Mumbai, Dec. 5

Sun Pharma’s generic drugs business in the US received a shot in the arm, after Novartis dropped a patent infringement suit against it and Watson Pharmaceuticals Inc over its Alzheimers and dementia drug Exelon.


“Claims against the generic-drug companies were dismissed,” said a news-agency report, citing a court document filed late last month at the federal court in New York.

The development comes a little more than a month after Sun Pharma got regulatory approval from the US Food and Drug Administration to sell Rivastigmine Tartrate, the generic version of Exelon. However, it is still unclear when the company will launch the product in the US following the latest development.

contd on page 2...

More news from Business
Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
NEWS FROM OUR PARTNERS
©Network 18, 2009. All Rights Reserved